Data as of 1:21pm ET
| -0.47 / -1.46%|
The 7 analysts offering 12-month price forecasts for WuXi Pharmatech (Cayman) Inc have a median target of 40.00, with a high estimate of 45.00 and a low estimate of 31.00. The median estimate represents a +25.83% increase from the last price of 31.79.
The current consensus among 9 polled investment analysts is to Buy stock in WuXi Pharmatech (Cayman) Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.